Pharmaceutical economics and policy / Stuart O. Schweitzer.
Material type: TextPublisher: New York : Oxford University Press, 1997Description: ix, 246 pages : illustrations ; 24 cmContent type:- text
- unmediated
- volume
- 0195105249
- 9780195105247
- 388.476151
- HD9666.5 .S385 1997
Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Book | City Campus City Campus Main Collection | 388.476151 SCH (Browse shelf(Opens below)) | 1 | Available | A157532B |
Browsing City Campus shelves, Shelving location: City Campus Main Collection Close shelf browser (Hides shelf browser)
388.46099300222 STE From rails to rubber : the downhill ride of New Zealand trams / | 388.4609938 MAF The Mount Somers Tramway : 1887-1943, Mid-Canterbury, New Zealand / | 388.47409932 AUC Auckland regional parking study / | 388.476151 SCH Pharmaceutical economics and policy / | 389 POV Measurement and calculation / | 389.09 VAL The values of precision / | 389.109 NEA All done with mirrors : an exploration of measure, proportion, ratio and number : opus 2 / |
Includes bibliographical references and index.
Introduction -- 1. Pharmaceutical Industry Research and Development -- 2. Marketing Pharmaceuticals -- 3. The Demand for Pharmaceuticals -- 4. Pharmaceutical Prices -- 5. The Worldwide Market for Pharmaceuticals -- 6. Pricing Pharmaceuticals in a World Environment -- 7. The Timing of Drug Approvals in the United States and Abroad -- 8. Pharmaceutical Regulation and Cost Containment -- 9. Patent Protection -- 10. Evaluating New Drugs -- 11. Pharmaceuticals and Health Policy: A Look Ahead.
This book employs the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both a U.S. and worldwide perspective. Schweitzer discusses the industry both as a manufacturer of products and as a major player in the making of health-care decisions. He also analyzes the reasons for and results of the shift in the locus of demand for pharmaceuticals. At present, the demand of large managed-care organizations are more important than those of individual physicians in formulating the future direction of pharmaceutical research. HMOs make decisions about product access on behalf of hundreds of thousands of patients. Recent changes in the regulatory environment - including patent law and FDA approval policies - have also influenced the pharmaceutical sector and are therefore investigated in detail.
Pharmaceutical Economics and Policy provides an insightful and expert analysis of this complex sector, and suggests appropriate regulatory approaches to assure that both private and public objectives continue to be served. It provides the first comprehensive look at the economics of the pharmaceutical industry in over 25 years. Readable and balanced, it will serve as an authoritative source of information for students and researchers in health services, health administration, health economics and policy, as well as for policy analysis and economists in industry, managed care organizations, and hospitals.
Machine converted from AACR2 source record.
There are no comments on this title.